Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: INOVIO PHARMACEUTICALS, INC., Inovio Pharmaceuticals, Inc.
Client-Reported Lobbying Expenses
$760K
45 filings
Firm Income Reported for This Client
$1.1M
Not substituted for client expenses
Contract Awards
$12.0M
2 awards
Summary
INOVIO PHARMACEUTICALS is an organization, based in PA. Its political footprint includes $760K in client-reported lobbying expenses, $1.1 million in lobbying-firm income reported for this client, $12.0 million in government contracts. Lobbying activity focuses on Health Issues, Pharmacy, Budget/Appropriations, Defense. Their largest government contract source is Department of Defense at $12.0 million. Political activity spans from 2011 to 2024.
These are different money flows and are not added together: contributions and lobbying expenses flow out, while contract awards flow to the organization.
Lobbying Spend Trend
↓ 82% YoY
2024: $30K (complete years)
Activity data: Senate LDA · USAspending.gov